Asset Acquisitions and Disposals::STRIKING-OFF OF INDIRECT WHOLLY-OWNED SUBSIDIARY, DAC PHARMALAB PTE LTD
Issuer & Securities
Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No
Announcement Details
Announcement Title
Asset Acquisitions and Disposals
Date &Time of Broadcast
09-Dec-2021 18:01:05
Status
New
Announcement Sub Title
STRIKING-OFF OF INDIRECT WHOLLY-OWNED SUBSIDIARY, DAC PHARMALAB PTE LTD
Announcement Reference
SG211209OTHRWPBI
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached.
This announcement has been reviewed by the Sponsor, SAC Capital Private Limited. ("Sponsor").
This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement including the accuracy, completeness or correctness of any information, statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms Lee Khai Yinn, who can be contacted at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542, Telephone: +65 6232 3210.
Attachments
HPIL_Annt_Deregister Subsidiary_DAC.pdf
Total size =364K
Related Announcements
Related Announcements